地特胰岛素与甘精胰岛素治疗2型糖尿病临床疗效
被引量:5
摘要
在口服降糖药基础上增加基础胰岛素是2型糖尿病(T2DM)患者起始胰岛素治疗的一种有效选择。以往使用的长效胰岛素和中效胰岛素,作用持续时间不够长、夜间低血糖发生率高、引起体重增加多。长效胰岛素类似物在一定程度改善以上情况。本文比较加用地特胰岛素或甘精胰岛素治疗的有效性和安全性。
出处
《江苏医药》
CAS
北大核心
2013年第21期2647-2648,共2页
Jiangsu Medical Journal
参考文献5
-
1Hirsch lB. Intensifying insulin therapy in patients with type 2 diabets mellitu[J]. Am J Med, 2005, 118 (Suppl 5A).. 21S- 26S.
-
2Russell-Jones D, Simpson R, Hylleberg B, et al. Effects of QD insulin detemir or neutral protamine Hagedom on blood glucose control in patients with type 1 diabetes mellitus using a basal- bolus regimen[J] Clin Ther, 2004,26 (5) : 724-736.
-
3Phdis-Tsimikas. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetie drags in poorly controlled type 2 diabetes[J]. Clin Ther, 2006,28 (10) : 1569-1581.
-
4姜文清,吴学军,马捷,邹定.新型基础胰岛素类似物地特胰岛素[J].中国新药杂志,2007,16(6):493-496. 被引量:8
-
5Hennige AM, Sartorius T, Tschritter O, et al. Tissue selectivity of insulin detemir action in vivo[J]. Diabetologia, 2006,49(6) : 1274-1282.
二级参考文献11
-
1滕香宇.新型胰岛素类似物的研究进展[J].世界临床药物,2004,25(12):714-717. 被引量:17
-
2RUSSELL-JONES D.Insulin detemir:Improving the predictability of glycaemic control[J].Int J Obes Relat Metab Disord,2004,28(2):S29-S34.
-
3陆志诚.地特胰岛素:作用时间长达一天[N].医药经济报(医院周刊第11期),2006-01-25.
-
4SORAN H,YOUNIS N.Insulin detemir:a new basal insulin analogue[J].Diabetes Obes Metab,2006,8(1):26-30.
-
5Levemir[EB/OL].[2006-01-19].http://www.rxlist.com/cgi/generic4/levemir cp.htm.
-
6DANNE T,LUPKE K,WALTE K,et al.Insulin detemir is characterized by a consistent pharmacokinetic profile across agegroups in children,adolescents,and adults with type 1 diabetes[J].Diabetes Care,2003,26(11):3087-3092.
-
7HEISE T,NOSEK L,RONN BB,et al.Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes[J].Diabetes,2004,53(6):1614-1620.
-
8BOTT S,TUSEK C,JACOBSEN LV,et al.Insulin detemir under steady-state conditions:no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes[J].Diabet Med,2006,23(5):522-528.
-
9PHILIPPE V,JEAN-LOUIS S,SVEIN S,et al.Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart[J].Diabetes Care,2003,26(3):590-596.
-
10HERMANSEN K,DAVIES M,DEREZINSKI T,et al.A 26week,randomized,parallel,treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes[J].Diabetes Care,2006,29(6):1269-1274.
共引文献7
-
1张翼鸿,梅艳,谢晓滨.地特胰岛素联合门冬胰岛素与胰岛素泵对初发2型糖尿病胰岛功能影响的比较[J].黑龙江医学,2011,35(7):493-494. 被引量:13
-
2崔颖,潘玉荣.地特胰岛素联合三餐前诺和锐治疗2型糖尿病的疗效[J].中国社区医师(医学专业),2012,14(5):59-59.
-
3劳丹华,廖虹.地特胰岛素联合门冬胰岛素治疗难控脆性糖尿病临床观察[J].医药论坛杂志,2012,33(1):101-102. 被引量:5
-
4谢新荣,赵妮,赵弋于,欧玉明.地特胰岛素对初治2型糖尿病的疗效观察[J].广西医学,2013,35(2):193-195. 被引量:3
-
5陈业倩.地特胰岛素联合重和林R(重组人胰岛素)与胰岛素泵治疗糖尿病疗效比较[J].中外医学研究,2013,11(26):13-14.
-
6许剑萍.地特胰岛素联合门冬胰岛素皮下注射治疗T2DM效果观察[J].中国医药科学,2014,4(18):54-55. 被引量:2
-
7李琳,王远征,刘小燕,毛丹,张阳,崔月,李水娇,刘云,张敬.重和林M30治疗新诊断的2型糖尿病的临床疗效观察[J].实用糖尿病杂志,2015,11(1):44-45.
同被引文献58
-
1王淑平,赵秀云.地特胰岛素联合阿卡波糖治疗血糖控制不佳的2型糖尿病患者的疗效[J].中国老年学杂志,2014,34(1):243-244. 被引量:9
-
2廖勤,梁泽容,屈春梅.两种基础胰岛素类似物——地特胰岛素与甘精胰岛素治疗2型糖尿病临床效果比较[J].实用医院临床杂志,2010,7(4):42-44. 被引量:25
-
3Dunseath G J,Atkinson M D,Owens D R.A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine:A single dose clamp study in people with type 2 diabetes[J].Diabetes&Metabolism,2013,39(6):537.
-
4Joaquín E.Caporale,BEcon.A Comparison of 1-Year Treatment Costs in Patients with Type2 Diabetes Following Initiation of Insulin Glargine or Insulin Detemir in Argentina[J].VALUE IN HEALTH REGIONAL,2014,14(19):15.
-
5Julio Rosenstock,Helena W Rodbard,Stephen C Bain,et al.One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to Hb A1ctarget[J].Journal of Diabetes and its Complications,2013,27(5):492.
-
6Meneghini LF,Rosenberg KH,Koenen C,et al. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the predictive 303 stud- y. Diabetes Obes Metab, 2007,3 .. 418-27.
-
7Rosenstock J, Daves M, Larsen J, et al. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia,2008, 3:408-416.
-
8Retnakaran R, Qi Y, Opsteen C, et al. lmtial short term inten- sive insulin therapy as a strategy for evaluating the preset- va- tion of beta-cell function with oral antidiabetic medications~ a pilot study with sitagliptin. Diabetes Obes Metab, 2010, 12; 909-915.
-
9Kato T,Tokubuchi I, Muraishi K, et al. Distinct pharmaco dy- namics of insulin glargine and insulin detemir., crossover com- parison in type 1 and type 2 diabetic patients on basal bolus regimen. Diabetes Res Clin Pract, 2010,90 .. e64-e66.
-
10谭世平,黄碧梧.地特胰岛素与甘精胰岛素控制2型糖尿病患者的疗效比较[J].中国医院药学杂志,2010,30(17):1474-1477. 被引量:22
引证文献5
-
1向敏,程新芹.地特胰岛素与甘精胰岛素联合格列美脲对2型糖尿病患者血糖及体质量的影响[J].实用临床医药杂志,2016,20(3):43-45. 被引量:31
-
2张映,柯正华.甘精胰岛素对比地特胰岛素治疗中国2型糖尿病的系统评价[J].中国糖尿病杂志,2016,24(6):517-523. 被引量:15
-
3张前进.长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性分析[J].糖尿病新世界,2017,20(4):81-82. 被引量:6
-
4杨柳,田丽,孟宪杰,刘洪梅,张晋冀.地特胰岛素联合阿卡波糖治疗2型糖尿病34例有效性观察[J].河北医科大学学报,2017,38(10):1132-1134. 被引量:12
-
5侯雨,张龙军,邱文娜,张帅,邓春颖.甘精胰岛素与地特胰岛素应用于中国2型糖尿病治疗的meta分析[J].现代医药卫生,2019,35(3):336-341. 被引量:2
二级引证文献63
-
1缑丽莎.格列美脲联合甘精胰岛素注射液治疗初诊2型糖尿病患者的疗效分析[J].中国合理用药探索,2019,0(12):108-110. 被引量:2
-
2赵艳云,夏晶晶,孟一帆.地特胰岛素联合阿卡波糖对老年糖尿病患者血糖控制的影响[J].实用糖尿病杂志,2018,14(6):18-19. 被引量:1
-
3肖学军.甘精胰岛素联合格列美脲对老年2型糖尿病患者血糖控制及体质量指数的影响[J].实用糖尿病杂志,2018,14(6):41-42. 被引量:2
-
4宁江颖,刘星君,张渭涛.口服降糖药联合胰岛素对糖尿病患者胰岛β细胞功能、骨代谢的影响[J].药物评价研究,2018,41(11):2056-2060. 被引量:2
-
5周启明.甘精胰岛素对2型糖尿病患者血糖控制及胰岛功能的影响[J].实用糖尿病杂志,2019,15(1):55-56.
-
6焦亮,张叔贵.重组甘精胰岛素联合格列美脲治疗2型糖尿病的临床疗效观察[J].中国医药指南,2016,14(21):60-60. 被引量:6
-
7林彬,林昱.甘精胰岛素联合格列美脲稳定2型糖尿病血糖水平的作用效果[J].海峡药学,2017,29(3):224-225. 被引量:3
-
8刘娜.磷酸西格列汀联合甘精胰岛素对老年2型糖尿病患者的影响[J].社区医学杂志,2017,15(8):68-69. 被引量:9
-
9李士军,左一宏.分析地特胰岛素结合格列美脲用于治疗老年2型糖尿病患者的临床效果[J].中西医结合心血管病电子杂志,2016,4(33):57-57. 被引量:5
-
10高琳,徐晶,苏振丽,张杨.糖尿病患者起始胰岛素治疗方案的选择及安全性评价[J].西部医学,2017,29(10):1385-1388. 被引量:5
-
1祁学成,陈延超,王梅,陈新岩,蒲新菊,黄晓婷.双水平气道正压通气联用呼吸兴奋剂治疗慢性阻塞性肺病急性加重期并发Ⅱ型呼吸衰竭临床分析[J].当代医学,2008,14(9):7-8. 被引量:3
-
2林启海,徐志军.应用大剂量山莨菪碱抢救有机磷中毒体会[J].中国药物与临床,2009,9(9):864-865.
-
3殷艳花,周海蒙.盐酸戊乙奎醚与阿托品治疗急性有机磷农药中毒的疗效分析[J].中华实用诊断与治疗杂志,2009,23(3):279-280. 被引量:14
-
4刘少俊,唐五良,沈守荣.重组人生长激素治疗肝硬化低蛋白血症的临床观察[J].湖南医科大学学报,2003,28(4):398-400. 被引量:2
-
5林宇彪,宁观林,吴一新.苯磺酸氨氯地平片与氢氯噻嗪片治疗老年高血压临床对比观察[J].内科,2015,10(1):15-16. 被引量:5
-
6王晓华,张秀琴.麝香保心丸治疗冠心病心绞痛临床观察[J].中国中医急症,2010,19(5):739-740. 被引量:9
-
7周伟雄.普米克令舒和博利康尼联合雾化吸入治疗慢性阻塞性肺病急性加重期的疗效观察[J].实用临床医学(江西),2006,7(9):54-55. 被引量:9
-
8夏斌,周阿旺.布地奈德和复方异丙托溴铵联合雾化吸入治疗慢性阻塞性肺病急性发作期的疗效[J].中国现代医生,2010,48(26):38-39. 被引量:16
-
9张凤革,郑文旭.雾化吸入布地奈德联合复方异丙托溴铵对老年慢性阻塞性肺疾病急性加重期患者的疗效及对降钙素原、C反应蛋白的影响[J].中国基层医药,2015,22(11):1676-1679. 被引量:5
-
10韩伟,周新.布地奈德雾化治疗在COPD急性加重期的应用[J].实用临床医药杂志,2004,8(2):6-8. 被引量:62